Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Source:
cnbc
October 20, 2026 · 05:50
From the publisher
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
About the source
CNBC
The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…
Wikidata Q1023912
Wikidata ↗
The original article opens on the publisher's website.
More from Automotive
View topic →Labor and the Coalition are poised to take a reckless gamble on AI. Haven’t they realised community support has collapsed? | Edward Santow and Sarah Sacher
guardianTech
Oct 20, 2026 · 07:00
Investors look to earnings to reset the bull market. The key level to watch on the S&P 500
cnbc
Oct 20, 2026 · 05:52
I’m a CTO. AI still needs your human expertise | Madhu Shashanka
guardianTech
Oct 20, 2026 · 05:30
Draymond Green says he's 'not Steph Curry,' wants to play another year even if he leaves Golden State Warriors
cnbc
Oct 20, 2026 · 05:00
AI adoption by industry shows what other sectors can learn
mitTechReview
Oct 20, 2026 · 05:00